Applications published 30 September 2009

Gas-filled microvesicles with targeting ligand in respect of FC-region of an antibody or therapeutic agent
Bracco Research 2104488*

Topical administration of Danazol
FemmePharma Holding 2104489*

Micronised particles of low-dosage strength active agents for powder formulations for inhalation
Chiesi Farmaceutici 2104490*

Hydrobromide salt of an anti-HIV compound
Tibotec Pharmaceuticals 2104491*

Oxygen supply for cell transplant and vascularisation
Beta O2 Technologies 2104492*

Use of 1) a polyglycol and 2) an active drug substance for a pharmaceutical compsn for 1) mitigating the risk of alcohol induced dose dumping and/or 2) reducing the risk of drug abuse
Egalet 2104493*

Method for reducing inflammatory responses and inflammation
Adelaide Research and Innovation Pty 2104494*

Methods of administering rapamycin analogues with anti-inflammatories using medical devices
Abbott Laboratories 2104495*

Use of nepafenac or derivatives thereof for treating dermatological disorders that may include an inflammatory immunoallergic component
Galderma Research &?Development 2104496*

Urea and sulphonamide derivatives as tafia inhibitors
Sanofi-Aventis 2104497*

Liquid formulations of phospholipid enzyme inhibitors
Wyeth 2104498*

Method and compsn for reducing reperfusion injury
Adelaide Research &?Innovation; James Cook University 2104499*

Substituted piperazines for the treatment of pain
Merck 2104500*

Methods of cancer treatment with IGF1R inhibitors
Schering 2104501*

Compsns and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
Savvipharm 2104502*

Morpholine dopamine agonists for the treatment of pain
Pfizer 2104503*

Preventing or reducing oxidative stress of oxidative cell injury by the administration of a water-insoluble cellulose derivative
Dow Global Technologies; United States Department of Agriculture 2104504*

Method and use for increasing efficacy of anti-adhesive compsns in controlling inflammation and pain
Warsaw Orthopedic 2104505*

Inhibitors of inflammatory cytokine transcription derived from HCMV protein IE2
University of Pittsburgh of the Commonwealth System of Higher Education; Suny Upstate Medical University 2104506*

T-140 peptide analogues having CXCR4 super-agonist activity for cancer therapy
Biokine Therapeutics 2104507*

Treating acute renal failure with soluble thrombomodulin variants
Eli Lilly; Indiana University Research and Technology 2104508*

Compsns and methods for treating pathologic angiogenesis and vascular permeability
University of Utah Research Foundation 2104509*

Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus
Ipsen Pharma 2104510*

Alpha B-crystallisation as a therapy for inflammation
The Board of Trustees of the Leland Stanford Junior University 2104511*

Streptococcus proteins, and their use in vaccination
Emergent Product Development UK 2104512*

OVR110 antibody compsns and methods of use
Diadexus 2104513*

Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity
Imclone 2104514*

Methods for preparing a polymer conjugate
Nektar Therapeutics 2104515*

Methods and compsns related to the structure and function of APOBEC3G
University of Rochester 2104516*

Photocatalyst, methods for deodorising, and methods for making a deodorizer system
Northrock Distribution 2104517*

A biodegradable osteogenic porous biomedical implant with impermeable membrane
Warsaw Orthopaedic 2104518*

Film-forming gel compsn for wound or skin care
Beiersdorf 2104519*

Method for producing a product having a polymer matrix, implants made thereof and use thereof
Jennissen, Herbert 2104520*

Tetrahydrobenzoisoxazole and tetrahydroindole derivatives as modulators of the mitotic motor protein
Merck Patent 2104664*

Imidazolone and imidazolidinone derivatives as 11B-HSD1 inhibitors for diabetes
F Hoffmann-La Roche 2104665*

Thiazole compound (as PPAR-delta ligand) and pharmaceutical, cosmetic and health food comprised thereof
Seoul National University Industry Foundation 2104666*

Synthesis of chromane derivatives in the presence of ionic liquids
Merck Patent 2104667*

Solvent addition and removal in the hydrogenation of catmint oil
EI duPont de Nemours 2104668*

Inhibitors of AKT activity
Merck; Banyu Pharmaceutical 2104669*

Novel triazinedione derivatives as GABA-P?receptor modulators
Addex Pharma 2104670*

Substituted heterocyclylcarbonylamino-acetic acid derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
Mutabilis 2104671*

2-(piperidin-4-yloxy)pyrimidin-4-amine derivatives as deoxycytidine kinase inhibitors for the treatment of cancer
Lexicon Pharmaceuticals 2104672*

New 2,4-dianilinopyrimidines, preparations thereof as drugs, pharmaceutical compositions and use thereof essentially as IKK inhibitors
Sanofi-Aventis 2104673*

Thiophene analogues for the treatment or prevention of lavivirus infections
Virochem Pharma 2104674*

Substituted 5H-pyrimidol[4,5-B] indoles, method for the production thereof, and use thereof for treating non-solid malignant tumours of the blood-producing system
The Medicines Company (Leipzig) 2104675*

Methods for preparing arene-bis (dicarboximide)-based semiconducting materials and related intermediates for preparing same
Polyera 2104676*

Spiropiperidine glycinamide derivatives
F Hoffmann-La Roche 2104677*